1. Home
  2. MTEK vs RGNT Comparison

MTEK vs RGNT Comparison

Compare MTEK & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$1.16

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.31

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEK
RGNT
Founded
2008
2004
Country
Israel
Israel
Employees
14
8
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
11.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MTEK
RGNT
Price
$1.16
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
351.5K
24.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$1.54
52 Week High
$4.27
$8.35

Technical Indicators

Market Signals
Indicator
MTEK
RGNT
Relative Strength Index (RSI) 46.03 25.56
Support Level $1.08 N/A
Resistance Level $1.44 $3.35
Average True Range (ATR) 0.13 0.25
MACD 0.01 -0.02
Stochastic Oscillator 38.46 1.56

Price Performance

Historical Comparison
MTEK
RGNT

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: